PATENT CLAIM ANALYSIS

Application Number: 15751782
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["544", "280000"]

Abstract:
Disclosed are a compound related to inhibiting the activity of an IRAK4 kinase, a pharmaceutical composition thereof, a use thereof in preparing drugs, a method in which same is used for inhibiting the activity of the IRAK4 kinase and a method in which same is used for treating and/or preventing IRAK4 kinase mediated diseases or conditions in mammals (especially humans). The compound has a structural formula I.

Claim (Index 12):
The method of  claim 11 , wherein the IRAK4-mediated disease is selected from the group consisting of autoimmune diseases, inflammatory diseases, heteroimmune conditions or diseases, thromboembolic diseases and cancers.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 88.0
- Lexical Diversity: 1.6087
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15022248', '15799315', '15314938', '14423078', '15257926']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.842024625328374
- 35 USC 102 Novelty (BERT): 0.5393214509167248
- Combined Prediction Score: 0.811754307887209
- Mean Citation Score: 378.723926
- Max Citation Score: 398.73517
- Similarity Product: 255.12390945224288

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test